101 related articles for article (PubMed ID: 1419884)
1. Estrogen receptor and C19-5-ene-steroid concentrations in the nuclear fraction from human breast carcinoma tissue.
Adams JB; Seymour-Munn K
J Steroid Biochem Mol Biol; 1992 Nov; 43(6):499-505. PubMed ID: 1419884
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
Adams JB; Archibald L; Seymour-Munn K
Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
[TBL] [Abstract][Full Text] [Related]
3. Expression of hydroxysteroid sulphotransferase is related to estrogen receptor status in human mammary cancer.
Adams JB; Phillips NS; Pewnim T
J Steroid Biochem; 1989 Oct; 33(4A):637-42. PubMed ID: 2554064
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells.
Adams J; Garcia M; Rochefort H
Cancer Res; 1981 Nov; 41(11 Pt 1):4720-6. PubMed ID: 6458355
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
6. Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue.
van Landeghem AA; Poortman J; Nabuurs M; Thijssen JH
Cancer Res; 1985 Jun; 45(6):2907-12. PubMed ID: 3157451
[TBL] [Abstract][Full Text] [Related]
7. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
8. Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs.
Simard J; Labrie F
J Steroid Biochem; 1987 May; 26(5):539-46. PubMed ID: 2953941
[TBL] [Abstract][Full Text] [Related]
9. Formation and turnover of long-chain fatty acid esters of 5-androstene-3 beta, 17 beta -diol in estrogen receptor positive and negative human mammary cancer cell lines in culture.
Adams JB; Martyn P; Smith DL; Nott S
Steroids; 1988; 51(3-4):251-67. PubMed ID: 3217953
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
Hackenberg R; Turgetto I; Filmer A; Schulz KD
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):597-603. PubMed ID: 8240982
[TBL] [Abstract][Full Text] [Related]
11. Delta-5-androstenediol and its sulphate in serum and urine of normal adults and patients with endocrine diseases.
Dikkeschei LD; Willemse PH; Wolthers BG; de Ruyter-Buitenhuis AW; Nagel GT
Clin Endocrinol (Oxf); 1993 Oct; 39(4):475-82. PubMed ID: 8287575
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
13. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin R; Labrie F
Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
[TBL] [Abstract][Full Text] [Related]
15. Uptake and concentration of steroid hormones in mammary tissues.
Thijssen JH; van Landeghem AA; Poortman J
Ann N Y Acad Sci; 1986; 464():106-16. PubMed ID: 2942072
[TBL] [Abstract][Full Text] [Related]
16. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
van Doorn LG; Poortman J; Thijssen JH; Schwarz F
Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
[TBL] [Abstract][Full Text] [Related]
17. Androstenediol complements estrogenic bioactivity during the menopausal transition.
Lasley BL; Chen J; Stanczyk FZ; El Khoudary SR; Gee NA; Crawford S; McConnell DS
Menopause; 2012 Jun; 19(6):650-7. PubMed ID: 22415563
[TBL] [Abstract][Full Text] [Related]
18. Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.
Bonney RC; Scanlon MJ; Reed MJ; Jones DL; Beranek PA; James VH
J Steroid Biochem; 1984 Jan; 20(1):501-4. PubMed ID: 6231424
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
20. Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast.
Nephew KP; Sheeler CQ; Dudley MD; Gordon S; Nayfield SG; Khan SA
Mol Cell Endocrinol; 1998 Aug; 143(1-2):133-42. PubMed ID: 9806358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
